| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/30/2004 | US20040267230 Flow regulator |
| 12/30/2004 | US20040267190 Kit, device and method for controlled delivery of oxidizing agent into the skin |
| 12/30/2004 | US20040267082 Device for treating headache |
| 12/30/2004 | US20040266965 polymerization of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate in water, then drying to form powder; cosmetics |
| 12/30/2004 | US20040266892 Method for the production of particles |
| 12/30/2004 | US20040266890 Methods and apparatuses for the comminution and stabilization of small particles |
| 12/30/2004 | US20040266883 Preventing, treating, or alleviating symptoms of any disease or clinical condition which condition is at least partly the result of a defect in the cystic fibrosis transmembrane conductance regulator by administering a composition comprising at least two curcuminoids; cystic fibrosis |
| 12/30/2004 | US20040266877 Stable liquid oral dosage pharmaceutical composition, comprising at least one thyroid hormone, 40% to 96% of ethanol by volume, a pH adjusting agent so that measured pH of composition is 9 to 12, and 4% to 50% water by volume; accurately delivers small doses of thyroid hormone; long shelf life |
| 12/30/2004 | US20040266869 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 12/30/2004 | US20040266836 Salt of acidic AT1-receptor antagonist and basic cardiovascular ingredient; potentiation or synergism; reduction of side effects |
| 12/30/2004 | US20040266830 Insulin sensitivity enhancer and second antidiabetic of different mechanism; suppressing hyperglycemia |
| 12/30/2004 | US20040266813 Injectable sustained-release microspheres of huperzine a compoounds |
| 12/30/2004 | US20040266807 Controlled release hydrocodone formulations |
| 12/30/2004 | US20040266806 Autoclaved methylnaltrexone preparation having reduced level of degradation products; storage stability; kits |
| 12/30/2004 | US20040266734 administering encapsulated bisphosphonate or gallium which inhibits and/or depletes phagocytic cells with high specificity, thereby suppressing the inflammatory response that occurs during and following myocardium necrosis; cardiovascular disorders |
| 12/30/2004 | US20040266725 Polysaccharide-containing compositions and use thereof |
| 12/30/2004 | US20040266719 immunostimulatory CpG oligonucleotide for inducing a mucosal immune response for treating a subject having an infection comprising enterovirus, calciviridae, vesicular stomatitis, rotavirus infection, Salmonella spp. infection, Helicobacter pyloris infection and M. intracellulare infection |
| 12/30/2004 | US20040266702 Topical treatment or prevention of ocular infections |
| 12/30/2004 | US20040266678 Methods and compositions for treating polycystic ovary syndrome |
| 12/30/2004 | US20040266662 Spheroidal hdl particles with a defined phospholipid composition |
| 12/30/2004 | US20040266026 Hybrid immobilized catalytic system with controlled permeability |
| 12/30/2004 | US20040265951 Biomimetic gelation system for use as surgical sealant and medical adhesive |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265403 nutraceuticals comprising plant extracts used as neuroprotectants and cognition activators |
| 12/30/2004 | US20040265395 Device for delivery of reducing agents to barrier membranes |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265391 Method of treating acute myocardial infarction |
| 12/30/2004 | US20040265390 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia |
| 12/30/2004 | US20040265389 Degradable gel and method for producing the same |
| 12/30/2004 | US20040265388 Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| 12/30/2004 | US20040265386 Gel compositions |
| 12/30/2004 | US20040265384 Composition for soluble films with a new hydrolyzed polysaccharide |
| 12/30/2004 | US20040265383 Compositions for parenteral administration and sustained-release of therapeutic agents |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265381 Antispasmodic agent spaced drug delivery system comprising an immediate release oxybutynin or salts and excipient; and a timed pulse release oxybutynin; urinary incontinence therapy |
| 12/30/2004 | US20040265380 Orodispersible effervescent tablets |
| 12/30/2004 | US20040265379 Administering 1900 to 2600 mg amoxycillin and an amount of potassium clavulanate such that the weight ratio of amoxycillin to clavulanate is 2:1 to 20:1, at a dosage regiment/interval of about 12 hours; pharmacokinetics; time release |
| 12/30/2004 | US20040265378 Method and compositions for producing granules containing high concentrations of biologically active substances |
| 12/30/2004 | US20040265377 High disintegrating oral solid vaccine dosage form comprising: immunogenic microsphere-antigen complex; adjuvant to enhances absorption or potentiate immunogenic response; mucoadhesive; andlow density dosage form matrix; drug delivery |
| 12/30/2004 | US20040265376 Orally deliverable; enhanced bioavailability; encapsulated in dissolution resistant material |
| 12/30/2004 | US20040265375 Matrix of silicified microcrystalline cellulose; antiinflammatory, antirheumatic, antiemetic, analgesic, antiepileptic, antipsychotic, antidepressant, hypnotic, antiulceric, prokinetic, antiasthmatic , vasodilator, antidiabetic, and/or hypolipidemic agents; Parkinson*s disease; cardiovascular disorders |
| 12/30/2004 | US20040265374 Pharmaceutical exipient having improved compressibility |
| 12/30/2004 | US20040265373 Immediate release tablet capable of being chewed or disintegrated in mouth; drug with tastemasking coating, and a matrix comprising hydroxyalkyl cellulose; mouth feel, stability |
| 12/30/2004 | US20040265372 Soft tablet containing high molecular weight cellulosics |
| 12/30/2004 | US20040265370 Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| 12/30/2004 | US20040265368 Combination compositions of camptothecins and fluoropyrimidines |
| 12/30/2004 | US20040265366 Nanocorpuscles having lipid bilayer with biliar salt and phospholipid and metallothionein in the interior; nervous system and neurodegenerative disorders; Alzheimer*s and Parkinson*s disease; multiple sclerosis, amyotrophic lateral sclerosis, viral and bacterial meningitis, spongiform encephalopathy |
| 12/30/2004 | US20040265364 Transdermal mixture for pain relief includes amitriptyline, clonidine, ketamine and antiinflammatory agent in pentravan gel; may contain local anesthetic lidocaine or EMLA; analgesics |
| 12/30/2004 | US20040265363 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 12/30/2004 | US20040265362 Adhesive, skin and/or nail permeation enhancer; drug contained in contact layer; and binders, crosslinking agents, softeners, solvents, fillers and/or antioxidants; occlusive backing; fungal infection treatment of onychomycosis |
| 12/30/2004 | US20040265359 Oral delivery formulations of L-glutamine |
| 12/30/2004 | US20040265356 Holder for drug core made of material impermeable to passage of drug and includes multiple openings formed by a laser for passage through to eye tissue |
| 12/30/2004 | US20040265354 Formulations for coated microprojections containing non-volatile counterions |
| 12/30/2004 | US20040265353 Delivering benzodiazepine drug comprising alprazolam, lorazepam, clonazepam, or midazolam; forming a depot beneath skin surface; attenuates panic attack if delivered into systemic circulation; applying microwave, exothermic, or electric heat to skin surface |
| 12/30/2004 | US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents |
| 12/30/2004 | US20040265344 Laxatives, antiinflammatory agents, antiallergens, and wound healing agents; treatment of hemorrhoids, bacterial infections of the anus, and constipation; side effect reduction |
| 12/30/2004 | US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors |
| 12/30/2004 | US20040265270 recombinant; Interferons; stabilized with a polyol, a non-reducing sugar or a amino acid; acetate buffer, albumin; mannitol, saccharose and glycine; storage stability |
| 12/30/2004 | US20040265244 nitrosyl-containing organometallic compound such as nitroprusside in dissolvable film decomposes at body temperature and in the presence of light to release *NO from the coating in an amount effective to prevent gingival and other oral mucosal diseases |
| 12/30/2004 | US20040265242 Administering drug to the respiratory tract of patient in a lower dosage than orally; treating Parkinson's or Alzheimer's disease; sleep, attention deficit hyperactivity, bipolar, and psychological disorders; headaches, antiepileptic agents; rescue therapy for a panic attack |
| 12/30/2004 | US20040265241 Methods for the inhalation administration of antibiotics |
| 12/30/2004 | US20040265240 Foamable iodine composition |
| 12/30/2004 | US20040265239 Buccal, polar and non-polar spray containing zolpidem |
| 12/30/2004 | US20040265238 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 12/30/2004 | US20040262435 post-processing of nanoscale powders of oxides, carbides, nitrides, borides, chalcogenides, metals, and alloys; to improve functional and processing characteristics for commercial applications |
| 12/30/2004 | DE20319249U1 Lutein-Konzentrat Lutein concentrate |
| 12/30/2004 | DE10301466A1 Body back-care strap has hand loops at each end and central moisture impermeable pad |
| 12/29/2004 | WO2004113451A1 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 12/29/2004 | WO2004113424A1 Method for preparing coprecipitate of substance sparingly soluble in water and polymer soluble in water |
| 12/29/2004 | WO2004113422A2 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device |
| 12/29/2004 | WO2004113379A1 Interferon gamma-like protein |
| 12/29/2004 | WO2004113332A1 Nasal preparations |
| 12/29/2004 | WO2004113286A2 Mucin synthesis inhibitors |
| 12/29/2004 | WO2004112837A1 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 12/29/2004 | WO2004112836A2 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | WO2004112827A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/29/2004 | WO2004112826A1 Freeze-dried fsh / lh formulations |
| 12/29/2004 | WO2004112814A1 Nail restructuring compositions for topical application |
| 12/29/2004 | WO2004112798A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 12/29/2004 | WO2004112796A1 Treatment of amd with combination of ingredients |
| 12/29/2004 | WO2004112791A1 Therapeutic and/or preventive agent for lung disease |
| 12/29/2004 | WO2004112789A1 Ophthalmic composition |
| 12/29/2004 | WO2004112778A1 Cisplatin preparation and process for producing the same |
| 12/29/2004 | WO2004112773A1 Pharmaceutical compositions used for immune disease treatment and improvement |
| 12/29/2004 | WO2004112770A1 Adhesive patch containing tulobuterol |
| 12/29/2004 | WO2004112765A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 12/29/2004 | WO2004112762A2 Pharmaceutical formulations of amyloid inhibiting compounds |
| 12/29/2004 | WO2004112760A1 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 12/29/2004 | WO2004112759A2 Skin patches |
| 12/29/2004 | WO2004112758A1 Hyaluronic acid nanoparticles |
| 12/29/2004 | WO2004112757A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| 12/29/2004 | WO2004112756A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 12/29/2004 | WO2004112755A1 Controlled release devices with lumens |
| 12/29/2004 | WO2004112754A1 Flupirtin injectable galenic form |
| 12/29/2004 | WO2004112753A1 Pharmaceutical compositions based on diclofenac derivate |
| 12/29/2004 | WO2004112752A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 12/29/2004 | WO2004112751A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 12/29/2004 | WO2004112750A2 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/29/2004 | WO2004112749A2 Ergonomic pointing device |
| 12/29/2004 | WO2004112748A2 Rate controlled release of a pharmaceutical agent in a biodegradable device |